Stay up to date

Mapped Outbreak Data

Read current official WHO and CDC news updates, listed below in the Newsfeeds section, descending from the most recent on top. See the notices from both organizations mapped globally immediately below.**

Skip maps

**Refresh if the map does not load immediately. Please note, not all news items map. See the news feeds below also.  


Skip Newsfeeds

WHO Disease Outbreaks

  • Novel Coronavirus – Japan (ex-China)...
    Fri, 17 Jan 2020
    On 15 January 2020, the Ministry of Health, Labour and Welfare, Japan (MHLW) reported an imported case of laboratory-confirmed 2019-novel coronavirus (2019-nCoV) from Wuhan, Hubei Province, China.

    The case-patient is male, between the age of 30-39 years, living in Japan.
  • Novel Coronavirus – Japan (ex-China)...
    Thu, 16 Jan 2020
    The Japanese Ministry of Health, Labour and Welfare, today informed the World Health Organization (WHO) of a confirmed case of a novel coronavirus (2019-nCoV) in a person who travelled to Wuhan, China. This is the second confirmed case of 2019-nCoV that has been detected outside of China, following confirmation of a case in Thailand on 13 January. Considering global travel patterns, additional cases in other countries are likely.

    Coronaviruses are a large family of viruses that cause illness ranging from the common cold to more severe diseases such as Middle East Respiratory Syndrome and Severe Acute Respiratory Syndrome. 2019-nCoV is a new strain that has not been previously identified in humans.
  • Ebola virus disease – Democratic Republic of the Congo ...
    Thu, 16 Jan 2020
    Fourteen new confirmed cases were reported from 8 to 14 January in the ongoing Ebola virus disease (EVD) outbreak in the Democratic Republic of the Congo.

CDC Travel Notices:


Click here to search for travel related diseases by country.

The Travel Clinical Assistant (TCA) is by the Georgia Department of Health.


CDC Morbidity and Mortality Weekly Report (MMWR):

  • EARLY RELEASE: Characteristics of Persons Who Report Using Only N...
    Fri, 17 Jan 2020
    Vitamin E acetate, which has been detected in tetrahydrocannabinol -containing e-cigarette, or vaping, products, is strongly linked to the e-cigarette, or vaping, product use-associated lung injury outbreak; however, evidence is not sufficient to rule out the contribution of other chemicals of concern, including chemicals in either THC- or non-THC-containing products, in some reported EVALI cases.
  • EARLY RELEASE: Update: Characteristics of a Nationwide Outbreak ...
    Fri, 17 Jan 2020
    CDC updates demographic characteristics, self-reported substance use, and hospitalization dates for e-cigarette, or vaping, product use-associated lung injury patients reported to CDC, as well as the distribution of emergency department visits related to e-cigarette, or vaping, products.


Current Journal Updates

Skip Current Journal Updates

Clinical Infectious Diseases Journal

This list includes items from the latest issue of the Clinical Infectious Diseases Journal.

  • In the Literature...
    Thu, 16 Jan 2020

  • A 67-year-old Man With Recurrent Multifocal Cellulitis...
    Thu, 16 Jan 2020
    A 67-year-old Caucasian man, an avid traveler with a history of hypertension, depression, and previous morbid obesity treated with bariatric surgery, presented with low-grade fever and recurrent left-ankle painful rash (Figure 1A). The patient noted the first episode 2 months prior to presentation when he presented with a poorly defined painful erythematous patch over his left ankle and leukocytosis. He was treated with cefazolin for suspected cellulitis and discharged on cephalexin with partial improvement. Infectious workup, including blood cultures, echocardiogram, and x-ray, was negative. Over the next few weeks he developed similar discrete episodes with new, noncontiguous rashes to other body parts, such as the abdomen, left shoulder (Figure 1B), right gluteal region, right elbow, and left knee that spontaneously resolved within a few days, sometimes without antibiotic treatment. A partial response to antihistamines, leg elevation, and doxycycline was noted, but rash and pain worsened with a short trial of steroids after initial improvement. Two days prior to admission, he again developed left-ankle painful erythematous rash spreading up to his knee, associated with fever. He had an extensive travel history with trips to China, India, South Asia, Canada, and Brazil in the last decade. Five months previously he had visited Hong Kong where he had a diarrheal illness consisting of 4–5 loose but not watery stools for 2 days that self-resolved. Three months previously he visited Morocco where he rode a camel. He lives in Missouri and has retired but volunteers with refugees hailing from the developing world receiving treatment for tuberculosis. He is a former sushi chef and eats raw seafood often. On presentation, he was febrile to 38.3°C but otherwise had stable vital signs. Laboratory data revealed leukocytosis (12 300 cells/μL) and elevated erythrocyte sedimentation rate (49 mm/h) and C-reactive protein (103 mg/L). Blood cultures were collected, and the patient was started on vancomycin and cefepime. Rheumatologic testing was negative, as was testing for syphilis, human immunodeficiency virus, tuberculosis, and Lyme disease. Left lower extremity computed tomography showed superficial soft tissue edema without osteomyelitis or abscess. Echocardiogram showed normal ventricular function without vegetations. Skin biopsy revealed sparse perivascular and interstitial inflammatory infiltrate consistent with cellulitis with negative tissue bacterial cultures. The aerobic bottle from 2 sets of blood cultures obtained on the day of admission yielded a pathogen whose microscopic features are shown in Figures 2 and 3.
  • News...
    Thu, 16 Jan 2020

Listen: New England Journal of Medicine

The New England Journal of Medicine is a weekly general medicine journal, and this audio news feed presents interviews with specialists.

  • NEJM Interview: Dr. Dominique Béhague on therapeutic strategies ...
    Wed, 15 Jan 2020
    Dr. Dominique Béhague is an associate professor of medicine, health, and society at Vanderbilt University and a reader in the Department of Global Health and Social Medicine at King’s College London. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. D.P. Béhague and Others. Dialogic Praxis — A 16-Year-Old Boy with Anxiety in Southern Brazil. N Engl J Med 2020;382:201-204.
  • NEJM Interview: Dr. David Cutler on the debate over Medicare for ...
    Wed, 08 Jan 2020
    Dr. David Cutler is a professor of applied economics at Harvard University. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L. Rosenbaum. Costs, Benefits, and Sacred Values — Why Health Care Reform Is So Fraught. N Engl J Med 2020;382:101-104.
  • NEJM Interview: Drs. James Shultz and Krista Nottage on climate-c...
    Wed, 01 Jan 2020
    James Shultz is director of the Center for Disaster and Extreme Event Preparedness at the University of Miami Miller School of Medicine. Krista Nottage is a Bahamian surgeon and New England Journal of Medicine editorial fellow. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J.M. Shultz and Others. Double Environmental Injustice — Climate Change, Hurricane Dorian, and the Bahamas. N Engl J Med 2020;382:1-3.

Emerging Infectious Diseases Journal:

This list contains articles published online ahead of print.


Center for Infectious Disease Research and Policy:

News from the University of Minnesota Center for Infectious Disease Research and Policy (CIDRAP).

Johns Hopkins Medicine RSS Feed:

Johns Hopkins Medicine science and medical news.

American Journal of Infection Control:

RSS feed including 'the latest published articles, both published in an issue and published as Articles in Press.'

  • Qualitative process evaluation of a central line-associated bloo...
    Central lines are intravenous catheters used to deliver medication or parenteral nutrition to the human body. These devices can deliver life-saving medication and fluids to seriously ill patients and may be in place for months.1 A central line-associated bloodstream infection (CLABSI) is a serious, and sometimes fatal, complication that occurs when microorganisms (ie, bacteria, fungi, etc.) enter the bloodstream through the central line and cause disease.1 These infections often lead to increased morbidity and mortality, as well as increased length of stay and health care costs.
  • Outpatient antimicrobial stewardship: Targets for urinary tract ...
    Urinary tract infections (UTIs) are one of the most common infectious diagnoses in the United States, accounting for 10.5 million outpatient visits in 2007.1,2 Of these visits, 5.4 million were seen in primary care offices and 2.2 million in emergency departments.2
  • Economic impact of antimicrobial-resistant bacteria outbreaks on...
    Antimicrobial resistance (AMR) has gained worldwide attention in not just the medical arena, but also political and economic contexts.1,2 The topic was even included in the agenda for the G7 Ise-Shima summit in 2016.3 To promote the AMR policy nationally and explain its validity to taxpayers, the Japanese government has begun to advocate studies on the societal/economic impact of AMR.4 Uematsu et al report that Methicillin-resistant Staphylococcus aureus (MRSA) caused 0.7% of community-acquired pneumonia, and hospitalization costs of the MRSA pneumonia were 1.7 times greater than pneumonia from other causes.